SCHEMBL20197341

SCHEMBL20197341

Fc1ccc(-c2nc(-c3ccc(NSC(F)(F)F)cc3Cl)cs2)c(CN2CCCC2)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1B1 Q16678 2/20 0.35
CYP1A2 P05177 1/20 0.35
KDM4E B2RXH2 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ACP1 P24666 2/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP1A1 P04798 1/20 0.33
MAOA P21397 1/20 0.33
EIF4E P06730 3/20 0.33
KCNH2 Q12809 2/20 0.32
SCN9A Q15858 2/20 0.32
ALDH1A1 P00352 1/20 0.32
BLM P54132 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
SCN1A P35498 1/20 0.32
SCN5A Q14524 1/20 0.32
SCN8A Q9UQD0 1/20 0.32
AXL P30530 1/20 0.32
EGFR P00533 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16535479 0.84 SCN1A (0.39) KDM4ESMN1; SMN2ACP1EIF4EALDH1A1
SCHEMBL20197318 0.80 EIF4E (0.46) CYP1B1CYP1A2KDM4ESMN1; SMN2CYP1A1
SCHEMBL20197309 0.76 CYP1B1 (0.41) CYP1B1CYP1A2KDM4ESMN1; SMN2CYP1A1
SCHEMBL20197302 0.74 SMN1; SMN2 (0.46) CYP1B1CYP1A2KDM4ESMN1; SMN2CYP1A1
SCHEMBL20197228 0.74 CYP1A1 (0.42) CYP1B1CYP1A2KDM4ESMN1; SMN2CYP1A1
SCHEMBL20197340 0.74 EIF4E (0.53) KDM4ESMN1; SMN2EIF4ESCN9AALDH1A1
SCHEMBL20197472 0.72 CYP1B1 (0.36) CYP1B1CYP1A2KDM4ESMN1; SMN2CYP1A1
SCHEMBL20197240 0.71 ALDH1A1 (0.53) CYP1B1CYP1A2KDM4ESMN1; SMN2CYP1A1
SCHEMBL20197278 0.71 CNR2 (0.39) KDM4ESMN1; SMN2
SCHEMBL20197292 0.71 SMN1; SMN2 (0.33) CYP1B1CYP1A2SMN1; SMN2CYP1A1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3038622-B1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE MEDIVATION TECH LLC (US) 2018-05-30 EP disclosed